Related Experiment Video
Updated: Feb 28, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Metronidazole-Induced Encephalopathy in a Patient With Metastatic Cancer
Anish K Sethi1, Elizabeth O'Connor2, Kenil Upadhyay2
1School of Medicine, Drexel University College of Medicine, West Reading, USA.
Abstract:
Metronidazole-induced encephalopathy (MIE) is a rare adverse effect from long-term metronidazole use. We describe a patient with metastatic cancer and complicated abscesses on long-term antibiotics who presented to the emergency department with acute encephalopathic features including reported weakness and confusion. Physical examination was remarkable for chronic right-sided weakness from a previous stroke and reported abnormal right-sided finger-to-nose testing, which may have been due to weakness from his prior stroke. Head CT was non-contributory, and brain MRI showed bilateral edema in cerebellar dentate nuclei, suggestive of MIE. We recommend having a low threshold for brain MRI in patients on long-term metronidazole to rule out other diagnoses and, in patients with lasting neurologic deficits, early neurology and palliative care involvement to improve quality of life.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

